|Title:||Dextromethorphan and an oxidase inhibitor for treating intractable conditions|
|Abstract:||Methods are disclosed for increasing the effectiveness of dextromethorphan in treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction comprising administering dextromethorphan in combination with a therapeutically effective dosage of a debrisoquin hydroxylase inhibitor. A preferred combination is dextromethorphan and the oxidative inhibitor quinidine.|
|Inventor(s):||Smith; Richard Alan (La Jolla, CA), Licht; Jonathan M. (San Diego, CA)|
|Assignee:||Center for Neurologic Study (La Jolla, CA)|
Patent Claim Types:|
see list of patent claims
|Use; Formulation; Dosage form;|
|PCT Filed||September 22, 1994||PCT Application Number:||PCT/US94/10771|
|PCT Publication Date:||March 28, 1996||PCT Publication Number:||WO96/09044|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0788359||► subscribe|
|European Patent Office||1634597||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.